טבע תעשיות פרמצבטיות

Teva Pharmaceutical Industries is the world's largest generic drug manufacturer, with its international headquarters located in Petah Tikva, Israel. The company is listed on the New York Stock Exchange under the ticker TEVA and is also traded on the Tel Aviv Stock Exchange. Teva is one of Israel's largest publicly traded companies by market capitalization.

Teva develops, manufactures, and markets generic and branded pharmaceuticals. Generic drugs form the core of its business: Teva supplies generic versions of a broad range of prescription medicines to markets in North America, Europe, and Asia. On the branded side, the most prominent product has been Copaxone (glatiramer acetate) for the treatment of multiple sclerosis, which for many years was the primary revenue driver in the branded segment. As Copaxone's patents expired, its dominance in the company's revenue mix declined.

Teva's key products include Copaxone (glatiramer acetate) for multiple sclerosis and AJOVY (fremanezumab) for the prevention and treatment of migraines, which received FDA approval in 2018. The company also maintains a broad portfolio of generic drugs sold under various trade names across different markets.

Teva competes with major generic pharmaceutical companies including Mylan (now Viatris), Sandoz (a Novartis division), and Sun Pharma. In recent years the company has faced significant challenges: a heavy debt load stemming in part from the 2016 acquisition of Actavis Generics from Allergan for approximately $40.5 billion — the largest acquisition in the company's history — as well as settlement agreements related to opioid-related litigation in the United States. The company has also faced regulatory investigations and lawsuits related to generic drug pricing in the U.S.

The international headquarters are in Petah Tikva. Teva maintains manufacturing, R&D, and administrative operations in Israel and is one of the largest employers in the domestic pharmaceutical sector. It operates production facilities in Israel alongside an extensive global manufacturing network.